__________ drug allergy prevalence is variable, ranging from 0.7% to 38.5%.

• A. Self-reported
• B. Laboratory-confirmed
• C. Clinician-confirmed
• D. Cross-reactive

Answer: (A)

The key idea is that how drug allergy is identified greatly changes how common it seems to be. Self-reported drug allergies capture anyone who believes they have an allergic reaction to a drug, and this hinges on memory, interpretation of symptoms, and health‑care access. Because many adverse effects or intolerances are mistaken for true allergies, and since awareness and testing vary across populations, the prevalence reported from self‑reports spans a wide range, from about 0.7% up to 38.5%.

This wide range reflects the imperfect nature of self‑report: it includes people who were told they were allergic, those who misinterpret side effects as allergies, and those who may no longer be true allergic after time or testing. In contrast, laboratory-confirmed or clinician-confirmed allergy uses objective criteria (tests, drug challenges, detailed history) and typically yields much lower and more consistent prevalence estimates. Cross-reactivity describes how often related drugs trigger similar reactions, not how common the condition is in the population.